Substance Use: Clinical Trials

5 trials for Substance Use, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 withdrawn. 5 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 4, Withdrawn 1
Phase 24Completed 3, Withdrawn 1

Follow Substance Use: new trials by email Literature Review of Substance Use trials Research Report on Substance Use

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder
Descovy or Truvada, ID-Cap System, Beiwe - HIV Infections, Substance Use
Phase 3CompletedBrigham and Women's Hospital402022-12-202026-07-21
Integration of (iSBIRT) for Teen Drug Use Into a Pediatric Network
iSBIRT - Substance Use
Phase 2 / Phase 3WithdrawnBoston Children's Hospital2012-07-012016-10-07
Familias Unidas: Preventing Substance Abuse in Hispanic Youth
Familias Unidas - Prevention, Family Function
Phase 2 / Phase 3CompletedUniversity of Miami7462010-08-012015-06-03
Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women
Safer Sex Skills Building (SSB) - HIV Infections, Substance Use
Phase 2 / Phase 3CompletedVirginia Commonwealth University3802008-12-012013-02-12
15 Year Follow-up of New Beginnings Program for Divorced Families
New Beginnings Program - Mental Disorder, Substance Use
Phase 2 / Phase 3CompletedArizona State University2402006-07-012011-08-02

Narrower conditions

Substance-Related Disorders (5)  ·  HIV Infections (2)  ·  Sexual Behavior (2)  ·  Alcoholism (1)  ·  Health Behavior (1)  ·  Marijuana Abuse (1)  ·  Medication Adherence (1)  ·  Mental Disorders (1)  ·  Risk Reduction Behavior (1)  ·  Safe Sex (1)  ·  Smoking (1)  ·  Treatment Adherence and Compliance (1)

Broader conditions

Chemically-Induced Disorders (5)  ·  Mental Disorders (4)  ·  Behavior (3)  ·  Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  Genital Diseases (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Infections (2)  ·  Lentivirus Infections (2)  ·  RNA Virus Infections (2)  ·  Retroviridae Infections (2)  ·  Sexually Transmitted Diseases (2)  ·  Sexually Transmitted Diseases, Viral (2)  ·  Urogenital Diseases (2)

Interventions

Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  emtricitabine tenofovir alafenamide (1)

Sponsors

Arizona State University (1)  ·  Boston Children's Hospital (1)  ·  Brigham and Women's Hospital (1)  ·  University of Miami (1)  ·  Virginia Commonwealth University (1)

Countries

United States (5)

Top investigators

Dace S Svikis, Ph.D. (1)  ·  Guillermo Prado, PhD (1)  ·  John R Knight, MD (1)  ·  Peter R Chai, MD MMS (1)  ·  Sharlene A Wolchik, Ph.D. (1)

Results publications

PMID 23750466, PMID 24484456, PMID 25367835, PMID 25382415, PMID 26465217, PMID 26692236, PMID 28207330, PMID 30514652

NIH funding

DP2DA056107 (1), P30MH068685 (1), P60MD002256 (1)